Verastem Taps LabCorp to Validate Companion Dx for Cancer Stem Cell Agent
January 09, 2013
Verastem Taps LabCorp to Validate Companion Dx for Cancer Stem Cell Agent
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- New Products: LabCorp's GeneSeq: Cardio
February 27, 2013 / Clinical Sequencing News - People in the News: Michael Aicher
February 27, 2013 / Clinical Sequencing News - LabCorp Injects $2M into SynapDx for Autism Test Development
February 21, 2013 / GenomeWeb Daily News - LabCorp Posts 3 Percent Q4 Revenue Growth; $1B Share Repurchase Authorized
February 8, 2013 / GenomeWeb Daily News - LabCorp Offering Veridex's CTC Test for Clinical Trials Research in China
January 18, 2013 / GenomeWeb Daily News